{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T04:12:50Z","timestamp":1746245570468,"version":"3.40.4"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obstetrics and Gynecology Clinics of North America"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ogc.2024.12.006","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T10:29:13Z","timestamp":1743416953000},"page":"331-346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic Options for Unscheduled Bleeding on Hormonal Contraception"],"prefix":"10.1016","volume":"52","author":[{"given":"Lule","family":"Rault","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shandhini","family":"Raidoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ogc.2024.12.006_bib1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.contraception.2007.06.008","article-title":"Contraceptive discontinuation attributed to method dissatisfaction in the United States","volume":"76","author":"Moreau","year":"2007","journal-title":"Contraception"},{"journal-title":"MMWR","article-title":"Selected Practice recommendations for contraceptive use","year":"2024","key":"10.1016\/j.ogc.2024.12.006_bib2"},{"key":"10.1016\/j.ogc.2024.12.006_bib3","article-title":"Recommendations for standardization of bleeding data analyses in contraceptive studies","volume":"112","author":"Md","year":"2022","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.ogc.2024.12.006_bib8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0010-7824(01)00302-X","article-title":"Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years","volume":"65","author":"Hidalgo","year":"2002","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.ogc.2024.12.006_bib9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0010-7824(96)00189-8","article-title":"Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system","volume":"54","author":"Suvisaari","year":"1996","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.ogc.2024.12.006_bib10","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0015-0282(16)56455-3","article-title":"Health during prolonged use of levonorgestrel 20 micrograms\/d and the copper TCu 380Ag intrauterine contraceptive devices: a multicenter study. International Committee for Contraception Research (ICCR)","volume":"61","author":"Sivin","year":"1994","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.ogc.2024.12.006_bib12","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/AOG.0b013e31828c65d8","article-title":"Management of initial bleeding or spotting after levonorgestrel-releasing intrauterine system placement: a randomized controlled trial","volume":"121","author":"S\u00f8rdal","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ogc.2024.12.006_bib13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijgo.2010.01.015","article-title":"Efficacy of mifepristone in reducing intermenstrual vaginal bleeding in users of the levonorgestrel intrauterine system","volume":"109","author":"Lal","year":"2010","journal-title":"Int J Gynaecol Obstet"},{"issue":"5","key":"10.1016\/j.ogc.2024.12.006_bib14","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.fertnstert.2011.08.021","article-title":"Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety","volume":"96","author":"Bouchard","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ogc.2024.12.006_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003449.pub4","article-title":"Treatment of vaginal bleeding irregularities induced by progestin only contraceptives","volume":"10","author":"Abdel-Aleem","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.ogc.2024.12.006_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0010-7824(99)00053-0","article-title":"A\u00a0randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant","volume":"60","author":"Zheng","year":"1999","journal-title":"Contraception"},{"issue":"Suppl 1","key":"10.1016\/j.ogc.2024.12.006_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/13625180801959931","article-title":"The effects of Implanon on menstrual bleeding patterns","volume":"13","author":"Mansour","year":"2008","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"3","key":"10.1016\/j.ogc.2024.12.006_bib18","first-page":"301","article-title":"Efficacy of celecoxib on controlling irregular uterine bleeding secondary to Jadelle use","volume":"92","author":"Buasang","year":"2009","journal-title":"J\u00a0Med Assoc Thail Chotmaihet Thangphaet"},{"issue":"Suppl 3","key":"10.1016\/j.ogc.2024.12.006_bib19","first-page":"S64","article-title":"The effect of mefenamic acid on controlling irregular uterine bleeding second to Implanon use","volume":"87","author":"Phaliwong","year":"2004","journal-title":"J\u00a0Med Assoc Thail Chotmaihet Thangphaet"},{"key":"10.1016\/j.ogc.2024.12.006_bib20","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.rr6504a1","article-title":"Selected Practice recommendations for contraceptive use, 2016","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"issue":"2","key":"10.1016\/j.ogc.2024.12.006_bib21","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.contraception.2016.10.001","article-title":"Tamoxifen for the treatment of breakthrough bleeding with the etonogestrel implant: a randomized controlled trial","volume":"95","author":"Simmons","year":"2017","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.ogc.2024.12.006_bib22","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/AOG.0000000000000974","article-title":"Short-Term treatment of bothersome bleeding for etonogestrel implant users using a 14-day oral contraceptive pill regimen: a randomized controlled trial","volume":"126","author":"Guiahi","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ogc.2024.12.006_bib23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/13625187.2016.1210122","article-title":"Combined oral contraceptive treatment for bleeding complaints with the etonogestrel contraceptive implant: a randomised controlled trial","volume":"21","author":"Hou","year":"2016","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"3","key":"10.1016\/j.ogc.2024.12.006_bib24","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0002-9378(96)70326-5","article-title":"Hormonal treatment for bleeding irregularities in Norplant implant users","volume":"174","author":"Alvarez-Sanchez","year":"1996","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl 2","key":"10.1016\/j.ogc.2024.12.006_bib25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/humrep\/11.suppl_2.109","article-title":"Oestrogen treatment for increased bleeding in Norplant users: preliminary results","volume":"11","author":"Witjaksono","year":"1996","journal-title":"Hum Reprod Oxf Engl"},{"issue":"1","key":"10.1016\/j.ogc.2024.12.006_bib26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0010-7824(90)90094-C","article-title":"Clinical assessment of treatments for prolonged bleeding in users of Norplant implants","volume":"42","author":"D\u00edaz","year":"1990","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.ogc.2024.12.006_bib27","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.contraception.2005.09.012","article-title":"The effect of tranexamic acid for treatment of irregular uterine bleeding secondary to Norplant use","volume":"73","author":"Phupong","year":"2006","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.ogc.2024.12.006_bib28","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/AOG.0000000000002810","article-title":"Ulipristal acetate for unscheduled bleeding in etonogestrel implant users: a randomized controlled trial","volume":"132","author":"Zigler","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ogc.2024.12.006_bib29","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/humrep\/dei273","article-title":"A\u00a0pilot study to assess the effect of three short-term treatments on frequent and\/or prolonged bleeding compared to placebo in women using Implanon","volume":"21","author":"Weisberg","year":"2006","journal-title":"Hum Reprod Oxf Engl"},{"issue":"9","key":"10.1016\/j.ogc.2024.12.006_bib30","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1093\/humrep\/15.9.1969","article-title":"Once a month administration of mifepristone improves bleeding patterns in women using subdermal contraceptive implants releasing levonorgestrel","volume":"15","author":"Cheng","year":"2000","journal-title":"Hum Reprod Oxf Engl"},{"issue":"1","key":"10.1016\/j.ogc.2024.12.006_bib31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.contraception.2004.02.009","article-title":"Effect of intermittent treatment with mifepristone on bleeding patterns in Norplant implant users","volume":"70","author":"Massai","year":"2004","journal-title":"Contraception"},{"issue":"Suppl 2","key":"10.1016\/j.ogc.2024.12.006_bib32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/humrep\/11.suppl_2.115","article-title":"The effect of transdermal oestradiol on bleeding pattern, hormonal profiles and sex steroid receptor distribution in the endometrium of Norplant users","volume":"11","author":"Boonkasemsanti","year":"1996","journal-title":"Hum Reprod Oxf Engl"},{"issue":"3","key":"10.1016\/j.ogc.2024.12.006_bib33","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/jog.14195","article-title":"Management of bleeding irregularities among etonogestrel implant users: is combined oral contraceptives pills or nonsteroidal anti-inflammatory drugs the better option?","volume":"46","author":"Upawi","year":"2020","journal-title":"J\u00a0Obstet Gynaecol Res"},{"issue":"8","key":"10.1016\/j.ogc.2024.12.006_bib34","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1093\/humrep\/dep081","article-title":"A\u00a0randomized controlled trial of treatment options for troublesome uterine bleeding in Implanon users","volume":"24","author":"Weisberg","year":"2009","journal-title":"Hum Reprod Oxf Engl"},{"issue":"2","key":"10.1016\/j.ogc.2024.12.006_bib35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.contraception.2009.02.008","article-title":"Menstrual pattern changes from levonorgestrel subdermal implants and DMPA: systematic review and evidence-based comparisons","volume":"80","author":"Hubacher","year":"2009","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.ogc.2024.12.006_bib36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0010-7824(88)90038-8","article-title":"Vaginal bleeding patterns among women using one natural and eight hormonal methods of contraception","volume":"38","author":"Belsey","year":"1988","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.ogc.2024.12.006_bib37","doi-asserted-by":"crossref","first-page":"351.e1-12","DOI":"10.1016\/j.ajog.2008.04.048","article-title":"Physiologic and psychologic symptoms associated with use of injectable contraception and 20 microg oral contraceptive pills","volume":"199","author":"Berenson","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ogc.2024.12.006_bib38","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1542\/peds.94.5.687","article-title":"A\u00a0prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception","volume":"94","author":"Cromer","year":"1994","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.ogc.2024.12.006_bib39","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.contraception.2004.04.003","article-title":"Effect of mefenamic acid on controlling irregular uterine bleeding in DMPA users","volume":"70","author":"Tantiwattanakul","year":"2004","journal-title":"Contraception"},{"issue":"Suppl 2","key":"10.1016\/j.ogc.2024.12.006_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/humrep\/11.suppl_2.1","volume":"11","author":"Said","year":"1996","journal-title":"Hum Reprod Oxf Engl"},{"key":"10.1016\/j.ogc.2024.12.006_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2024.109425","article-title":"Clomiphene citrate as a new modality in management of vaginal bleeding with depomedroxyprogesterone acetate (DMPA): a randomized controlled trial","volume":"206","author":"Shaheen","year":"2024","journal-title":"Steroids"},{"issue":"4","key":"10.1016\/j.ogc.2024.12.006_bib42","first-page":"461","article-title":"The effect of tranexamic acid for treatment irregular uterine bleeding secondary to DMPA use","volume":"92","author":"Senthong","year":"2009","journal-title":"J\u00a0Med Assoc Thail Chotmaihet Thangphaet"},{"issue":"10\u201313","key":"10.1016\/j.ogc.2024.12.006_bib43","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0039-128X(03)00132-6","article-title":"Mifepristone for the prevention of breakthrough bleeding in new starters of depo-medroxyprogesterone acetate","volume":"68","author":"Jain","year":"2003","journal-title":"Steroids"},{"issue":"2 Pt 2","key":"10.1016\/j.ogc.2024.12.006_bib45","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0002-9378(99)70719-2","article-title":"Cycle control with oral contraceptives: a review of the literature","volume":"180","author":"Thorneycroft","year":"1999","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ogc.2024.12.006_bib46","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0010-7824(97)00025-5","volume":"55","author":"Endrikat","year":"1997","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.ogc.2024.12.006_bib47","first-page":"163","article-title":"Cycle control, tolerability, and satisfaction among women switching from 30-35 microg ethinyl estradiol-containing oral\u00a0contraceptives to the triphasic norgestimate\/25 microg ethinyl estradiol-containing oral contraceptive Ortho Tri-Cyclen LO","volume":"48","author":"Poindexter","year":"2003","journal-title":"Int J Fertil Womens Med"},{"issue":"3","key":"10.1016\/j.ogc.2024.12.006_bib48","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0010-7824(99)00026-8","article-title":"Clinical comparison of triphasic norgestimate\/35 micrograms ethinyl estradiol and monophasic norethindrone acetate\/20 micrograms ethinyl estradiol. Cycle control, lipid effects, and user satisfaction","volume":"59","author":"Sulak","year":"1999","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.ogc.2024.12.006_bib49","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0010-7824(01)00214-1","article-title":"Comparison of a novel norgestimate\/ethinyl estradiol oral contraceptive (Ortho Tri-Cyclen Lo) with the oral contraceptive Loestrin Fe 1\/20","volume":"63","author":"Hampton","year":"2001","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.ogc.2024.12.006_bib50","first-page":"653","article-title":"Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial","volume":"101","author":"Miller","year":"2003","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ogc.2024.12.006_bib51","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0010-7824(03)00141-0","article-title":"A\u00a0multicenter, randomized study of an extended cycle oral contraceptive","volume":"68","author":"Anderson","year":"2003","journal-title":"Contraception"},{"issue":"7","key":"10.1016\/j.ogc.2024.12.006_bib52","article-title":"Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception","volume":"2014","author":"Edelman","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.ogc.2024.12.006_bib53","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1210\/jc.2007-2287","article-title":"Effects of continuous versus cyclical oral contraception: a randomized controlled trial","volume":"93","author":"Legro","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ogc.2024.12.006_bib54","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/AOG.0b013e3181842071","article-title":"Frequency and management of breakthrough bleeding with continuous use of the transvaginal contraceptive ring: a randomized controlled trial","volume":"112","author":"Sulak","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ogc.2024.12.006_bib55","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0010-7824(95)00270-7","article-title":"The effect of desogestrel, gestodene, and other factors on spotting and bleeding","volume":"53","author":"Rosenberg","year":"1996","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.ogc.2024.12.006_bib56","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.contraception.2012.08.005","article-title":"Treatment of unscheduled bleeding in women using extended- or continuous-use combined hormonal contraception: a systematic review","volume":"87","author":"Godfrey","year":"2013","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.ogc.2024.12.006_bib57","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/01.AOG.0000199950.64545.16","article-title":"Continuous oral contraceptives: are bleeding patterns dependent on the hormones given?","volume":"107","author":"Edelman","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ogc.2024.12.006_bib58","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/AOG.0b013e3181beab47","article-title":"Cycle control with a 21-day compared with a 24-day oral contraceptive pill: a randomized controlled trial","volume":"114","author":"Kaunitz","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ogc.2024.12.006_bib59","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.contraception.2009.03.013","article-title":"Bleeding pattern with drospirenone 3\u00a0mg+ethinyl estradiol 20 mcg 24\/4 combined oral contraceptive compared with desogestrel 150 mcg+ethinyl estradiol 20 mcg 21\/7 combined oral contraceptive","volume":"80","author":"Anttila","year":"2009","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.ogc.2024.12.006_bib60","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/AOG.0b013e31820095a2","article-title":"Effectiveness of oral contraceptive pills in a large U.S. cohort comparing progestogen and regimen","volume":"117","author":"Dinger","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ogc.2024.12.006_bib61","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.contraception.2011.08.006","article-title":"A\u00a0randomized controlled trial of subantimicrobial-dose doxycycline to prevent unscheduled bleeding with continuous oral contraceptive pill use","volume":"85","author":"Kaneshiro","year":"2012","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.ogc.2024.12.006_bib62","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/AOG.0b013e3181e0119c","article-title":"Treatment of unscheduled bleeding in continuous oral contraceptive users with doxycycline: a randomized controlled trial","volume":"115","author":"Kaneshiro","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ogc.2024.12.006_bib63","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0010-7824(82)90015-4","article-title":"Endometrial morphology and peripheral steroid levels in women with and without intermenstrual bleeding during contraception with the 300 microgram norethisterone (NET) minipill","volume":"25","author":"Johannisson","year":"1982","journal-title":"Contraception"},{"issue":"10","key":"10.1016\/j.ogc.2024.12.006_bib64","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1093\/humrep\/17.10.2588","article-title":"Improving cycle control in progestogen-only contraceptive pill users by intermittent treatment with a new anti-progestogen","volume":"17","author":"Gemzell-Danielsson","year":"2002","journal-title":"Hum Reprod Oxf Engl"},{"issue":"7","key":"10.1016\/j.ogc.2024.12.006_bib65","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/17512433.2020.1783247","article-title":"Drospirenone 4\u00a0mg-only pill (DOP) in 24+4 regimen: a new option for oral contraception","volume":"13","author":"Chiara Del Savio","year":"2020","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.ogc.2024.12.006_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231856","article-title":"Bleeding profile of women using a drospirenone-only pill 4\u00a0mg over nine cycles in comparison with desogestrel 0.075\u00a0mg","volume":"15","author":"Palacios","year":"2020","journal-title":"PloS One"},{"issue":"12","key":"10.1016\/j.ogc.2024.12.006_bib67","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1080\/09513590.2021.1963432","article-title":"Overall and bleeding-related discontinuation rates of a new oral contraceptive containing 4\u00a0mg drospirenone only in a 24\/4 regimen and comparison to 0.075\u00a0mg desogestrel","volume":"37","author":"Regidor","year":"2021","journal-title":"Gynecol Endocrinol"}],"container-title":["Obstetrics and Gynecology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854524001013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854524001013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T22:51:04Z","timestamp":1746226264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889854524001013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0889854524001013"],"URL":"https:\/\/doi.org\/10.1016\/j.ogc.2024.12.006","relation":{},"ISSN":["0889-8545"],"issn-type":[{"type":"print","value":"0889-8545"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic Options for Unscheduled Bleeding on Hormonal Contraception","name":"articletitle","label":"Article Title"},{"value":"Obstetrics and Gynecology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ogc.2024.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}